To determine the patterns of usage of bacille Calmette-Guerin (BCG) va
ccine in Victoria and assess whether the vaccine was being administere
d to those in high-risk groups, as identified by the National Health a
nd Medical Research Council, an audit of BCG vaccine unit sales and ex
penditure, over the past four years was conducted. A postal survey cov
ering all registered Victorian BCG vaccinators inquired about BCG vacc
ination practices during 1993. Vaccine sales and expenditure had nearl
y doubled since 1991. The number of registered vaccinators had also in
creased. The survey response rate was 77 per cent, (228 of 295). Half
of the vaccinators were working in general practice, 11 per cent of va
ccinators used no set guideline for client selection, 69 per cent vacc
inated fewer than 25 people in 1993, 26 per cent had vaccinated neonat
es (mainly southeast Asian), with few of these vaccinations being carr
ied out in maternity hospitals. Tertiary students and ethnic groups we
re the most commonly vaccinated groups. Only small amounts of BCG were
being given to people outside risk groups, mainly travellers and anxi
ous public. There has been significant increase in numbers of register
ed vaccinators and use of BCG with much wastage. Application of guidel
ines was inconsistent and coverage of high-risk groups varied. Despite
some selection for vaccination by personal choice, little vaccine app
eared to be used in nonrecommended groups. Subsequent changes in pract
ice have resulted, including publicising and clarifying guidelines, re
duction in the number of vaccinators, vaccinator upgrading courses, an
d restructuring of the vaccine ordering system.